Health product recall

Lacosamide 10mg/ml : Presence of particulate matter in affected lot.

Last updated

Summary

Product
Lacosamide Injection 10mg/ml
Issue
Health products - Product quality
What to do

Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.

Distribution
National

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot numbers

LACOSAMIDE INJECTION, USP

LACOSAMIDE INJECTION, USP

DIN 02541343

Solution

LACOSAMIDE 10mg/mL

2302208.1

Issue

Presence of particulate matter in affected lot.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Wholesalers, Health Care Establishments

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Hikma Canada Limited 5995 Avenbury Road, Suite 804, Mississauga, Ontario L5R 3P9

Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Identification number
RA-76893

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe